HLA-DRB5: Difference between revisions

Jump to navigation Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
m (Bot: HTTP→HTTPS (v470))
 
Line 1: Line 1:
{{PBB_Controls
{{Infobox_gene}}
| update_page = yes
'''HLA class II histocompatibility antigen, DRB5 beta chain''' is a [[protein]] that in humans is encoded by the ''HLA-DRB5'' [[gene]].<ref name = "Entrez_Gene_3127">{{cite web | title = Entrez Gene: HLA-DRB5 major histocompatibility complex, class II, DR beta 5| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3127| accessdate = }}</ref>
| require_manual_inspection = no
 
| update_protein_box = yes
== Function ==
| update_summary = yes
The [[protein]] encoded by this gene belongs to the [[MHC class II|HLA class II]] beta chain [[Homology (biology)#Paralogy|paralogues]]. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the [[immune system]] by presenting peptides derived from extracellular proteins. Class II molecules are expressed in [[antigen presenting cell]]s (APC: B lymphocytes, dendritic cells, macrophages).<ref name = "Entrez_Gene_3127"/>
| update_citations = yes
 
}}
== Gene structure and polymorphisms ==
The beta chain is approximately 26-28 kDa. It is encoded by 6 [[exon]]s, exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular [[protein domain|domains]], exon 4 encodes the [[transmembrane protein|transmembrane]] domain and exon 5 encodes the [[cytoplasm]]ic tail. Within the DR molecule the beta chain contains all the [[polymorphism (biology)|polymorphism]]s specifying the peptide binding specificities. Hundreds of DRB1 [[allele]]s have been described and typing for these polymorphisms is routinely done for bone marrow and kidney transplantation.<ref name = "Entrez_Gene_3127"/>


<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
== Gene expression ==
{{GNF_Protein_box
[[HLA-DRB1|DRB1]] is expressed at a level five times higher than its paralogues [[HLA-DRB3|DRB3]], [[HLA-DRB4|DRB4]] and DRB5. DRB1 is present in all individuals. Allelic variants of DRB1 are linked with either none or one of the genes DRB3, DRB4 and DRB5. The presence of DRB5 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.<ref name = "Entrez_Gene_3127"/>
| image = PBB_Protein_HLA-DRB5_image.jpg
| image_source = [[Protein_Data_Bank|PDB]] rendering based on 1aqd.
| PDB = {{PDB2|1aqd}}, {{PDB2|1d5m}}, {{PDB2|1dlh}}, {{PDB2|1fv1}}, {{PDB2|1fyt}}, {{PDB2|1h15}}, {{PDB2|1hqr}}, {{PDB2|1hxy}}, {{PDB2|1j8h}}, {{PDB2|1jwm}}, {{PDB2|1jws}}, {{PDB2|1jwu}}, {{PDB2|1kg0}}, {{PDB2|1klg}}, {{PDB2|1klu}}, {{PDB2|1lo5}}, {{PDB2|1pyw}}, {{PDB2|1r5i}}, {{PDB2|1seb}}, {{PDB2|1sje}}, {{PDB2|1sjh}}, {{PDB2|1t5w}}, {{PDB2|1t5x}}, {{PDB2|1zgl}}, {{PDB2|2g9h}}, {{PDB2|2iam}}, {{PDB2|2ian}}, {{PDB2|2icw}}, {{PDB2|2ipk}}, {{PDB2|2oje}}
| Name = Major histocompatibility complex, class II, DR beta 5
| HGNCid = 4953
| Symbol = HLA-DRB5
| AltSymbols =;
| OMIM = 604776
| ECnumber = 
| Homologene = 88657
| MGIid = 
| Function = {{GNF_GO|id=GO:0032395 |text = MHC class II receptor activity}}
| Component = {{GNF_GO|id=GO:0005887 |text = integral to plasma membrane}} {{GNF_GO|id=GO:0016020 |text = membrane}} {{GNF_GO|id=GO:0016021 |text = integral to membrane}} {{GNF_GO|id=GO:0042613 |text = MHC class II protein complex}}
| Process = {{GNF_GO|id=GO:0002504 |text = antigen processing and presentation of peptide or polysaccharide antigen via MHC class II}} {{GNF_GO|id=GO:0006955 |text = immune response}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 3127
    | Hs_Ensembl = 
    | Hs_RefseqProtein = NP_002116
    | Hs_RefseqmRNA = NM_002125
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = 
    | Hs_GenLoc_start = 
    | Hs_GenLoc_end = 
    | Hs_Uniprot = 
    | Mm_EntrezGene = 
    | Mm_Ensembl = 
    | Mm_RefseqmRNA = 
    | Mm_RefseqProtein = 
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 
    | Mm_GenLoc_start = 
    | Mm_GenLoc_end = 
    | Mm_Uniprot = 
  }}
}}
'''Major histocompatibility complex, class II, DR beta 5''', also known as '''HLA-DRB5''', is a human [[gene]].<ref>{{cite web | title = Entrez Gene: HLA-DRB5 major histocompatibility complex, class II, DR beta 5| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3127| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
==See also==
{{PBB_Summary
* [[HLA-DR]]
| section_title =  
| summary_text = HLA-DRB5 belongs to the HLA class II beta chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DRA) and a beta (DRB) chain, both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The beta chain is approximately 26-28 kDa and its gene contains 6 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. The presence of DRB5 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.<ref name="entrez">{{cite web | title = Entrez Gene: HLA-DRB5 major histocompatibility complex, class II, DR beta 5| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=3127| accessdate = }}</ref>
}}


==References==
==References==
{{reflist|2}}
{{reflist}}
 
==Further reading==
==Further reading==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal  | author=Lau M, Terasaki PI, Park MS |title=International Cell Exchange, 1994. |journal=Clinical transplants |volume= |issue=  |pages= 467-88 |year= 1995 |pmid= 7547576 |doi=  }}
*{{cite journal  |vauthors=Lau M, Terasaki PI, Park MS |title=International Cell Exchange, 1994. |journal=Clinical transplants |volume= |issue=  |pages= 467–88 |year= 1995 |pmid= 7547576 |doi=  }}
*{{cite journal  | author=Dong RP, Kimura A, Sasazuki T |title=Sequence analysis of three novel DRw14-DRB1 alleles. |journal=Immunogenetics |volume=36 |issue= 2 |pages= 130-3 |year= 1992 |pmid= 1612646 |doi=  }}
*{{cite journal  |vauthors=Dong RP, Kimura A, Sasazuki T |title=Sequence analysis of three novel DRw14-DRB1 alleles. |journal=Immunogenetics |volume=36 |issue= 2 |pages= 130–3 |year= 1992 |pmid= 1612646 |doi=10.1007/BF00215291 }}
*{{cite journal | author=Piatier-Tonneau D, Gastinel LN, Amblard F, ''et al.'' |title=Interaction of CD4 with HLA class II antigens and HIV gp120. |journal=Immunogenetics |volume=34 |issue= 2 |pages= 121-8 |year= 1991 |pmid= 1869305 |doi=  }}
*{{cite journal   |vauthors=Piatier-Tonneau D, Gastinel LN, Amblard F, etal |title=Interaction of CD4 with HLA class II antigens and HIV gp120. |journal=Immunogenetics |volume=34 |issue= 2 |pages= 121–8 |year= 1991 |pmid= 1869305 |doi=10.1007/BF00211424 }}
*{{cite journal | author=Nong Y, Kandil O, Tobin EH, ''et al.'' |title=The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1. |journal=Cell. Immunol. |volume=132 |issue= 1 |pages= 10-6 |year= 1991 |pmid= 1905983 |doi= }}
*{{cite journal   |vauthors=Nong Y, Kandil O, Tobin EH, etal |title=The HIV core protein p24 inhibits interferon-gamma-induced increase of HLA-DR and cytochrome b heavy chain mRNA levels in the human monocyte-like cell line THP1. |journal=Cell. Immunol. |volume=132 |issue= 1 |pages= 10–6 |year= 1991 |pmid= 1905983 |doi=10.1016/0008-8749(91)90002-S  }}
*{{cite journal  | author=Rosenstein Y, Burakoff SJ, Herrmann SH |title=HIV-gp120 can block CD4-class II MHC-mediated adhesion. |journal=J. Immunol. |volume=144 |issue= 2 |pages= 526-31 |year= 1990 |pmid= 1967269 |doi=  }}
*{{cite journal  |vauthors=Rosenstein Y, Burakoff SJ, Herrmann SH |title=HIV-gp120 can block CD4-class II MHC-mediated adhesion. |journal=J. Immunol. |volume=144 |issue= 2 |pages= 526–31 |year= 1990 |pmid= 1967269 |doi=  }}
*{{cite journal | author=Callahan KM, Fort MM, Obah EA, ''et al.'' |title=Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. |journal=J. Immunol. |volume=144 |issue= 9 |pages= 3341-6 |year= 1990 |pmid= 1970352 |doi=  }}
*{{cite journal   |vauthors=Callahan KM, Fort MM, Obah EA, etal |title=Genetic variability in HIV-1 gp120 affects interactions with HLA molecules and T cell receptor. |journal=J. Immunol. |volume=144 |issue= 9 |pages= 3341–6 |year= 1990 |pmid= 1970352 |doi=  }}
*{{cite journal | author=Petersdorf EW, Griffith RL, Erlich HA, ''et al.'' |title=Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes. |journal=Immunogenetics |volume=32 |issue= 2 |pages= 96-103 |year= 1990 |pmid= 1975801 |doi=  }}
*{{cite journal   |vauthors=Petersdorf EW, Griffith RL, Erlich HA, etal |title=Unique sequences for two HLA-DRB1 genes expressed on distinct DRw6 haplotypes. |journal=Immunogenetics |volume=32 |issue= 2 |pages= 96–103 |year= 1990 |pmid= 1975801 |doi=10.1007/BF00210446 }}
*{{cite journal  | author=Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ |title=Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 22 |pages= 9052-6 |year= 1991 |pmid= 1978941 |doi= }}
*{{cite journal  |vauthors=Bowman MR, MacFerrin KD, Schreiber SL, Burakoff SJ |title=Identification and structural analysis of residues in the V1 region of CD4 involved in interaction with human immunodeficiency virus envelope glycoprotein gp120 and class II major histocompatibility complex molecules. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=87 |issue= 22 |pages= 9052–6 |year= 1991 |pmid= 1978941 |doi=10.1073/pnas.87.22.9052  | pmc=55099  }}
*{{cite journal  | author=Gyllensten UB, Sundvall M, Erlich HA |title=Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=88 |issue= 9 |pages= 3686-90 |year= 1991 |pmid= 2023919 |doi=  }}
*{{cite journal  |vauthors=Gyllensten UB, Sundvall M, Erlich HA |title=Allelic diversity is generated by intraexon sequence exchange at the DRB1 locus of primates. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=88 |issue= 9 |pages= 3686–90 |year= 1991 |pmid= 2023919 |doi=10.1073/pnas.88.9.3686  | pmc=51517 }}
*{{cite journal  | author=Lee KW, Johnson AH, Hurley CK |title=Two divergent routes of evolution gave rise to the DRw13 haplotypes. |journal=J. Immunol. |volume=145 |issue= 9 |pages= 3119-25 |year= 1990 |pmid= 2212675 |doi=  }}
*{{cite journal  |vauthors=Lee KW, Johnson AH, Hurley CK |title=Two divergent routes of evolution gave rise to the DRw13 haplotypes. |journal=J. Immunol. |volume=145 |issue= 9 |pages= 3119–25 |year= 1990 |pmid= 2212675 |doi=  }}
*{{cite journal  | author=Gorski J |title=HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes. |journal=J. Immunol. |volume=143 |issue= 1 |pages= 329-33 |year= 1989 |pmid= 2471740 |doi=  }}
*{{cite journal  | author=Gorski J |title=HLA-DR beta-chain polymorphism. Second domain polymorphism reflects evolutionary relatedness of alleles and may explain public serologic epitopes. |journal=J. Immunol. |volume=143 |issue= 1 |pages= 329–33 |year= 1989 |pmid= 2471740 |doi=  }}
*{{cite journal  | author=Clayton LK, Sieh M, Pious DA, Reinherz EL |title=Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. |journal=Nature |volume=339 |issue= 6225 |pages= 548-51 |year= 1989 |pmid= 2543930 |doi= 10.1038/339548a0 }}
*{{cite journal  |vauthors=Clayton LK, Sieh M, Pious DA, Reinherz EL |title=Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. |journal=Nature |volume=339 |issue= 6225 |pages= 548–51 |year= 1989 |pmid= 2543930 |doi= 10.1038/339548a0 }}
*{{cite journal | author=Hurley CK, Gregersen PK, Gorski J, ''et al.'' |title=The DR3(w18),DQw4 haplotype differs from DR3(w17),DQw2 haplotypes at multiple class II loci. |journal=Hum. Immunol. |volume=25 |issue= 1 |pages= 37-50 |year= 1989 |pmid= 2565895 |doi=  }}
*{{cite journal   |vauthors=Hurley CK, Gregersen PK, Gorski J, etal |title=The DR3(w18),DQw4 haplotype differs from DR3(w17),DQw2 haplotypes at multiple class II loci. |journal=Hum. Immunol. |volume=25 |issue= 1 |pages= 37–50 |year= 1989 |pmid= 2565895 |doi=10.1016/0198-8859(89)90068-2 }}
*{{cite journal | author=Diamond DC, Sleckman BP, Gregory T, ''et al.'' |title=Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. |journal=J. Immunol. |volume=141 |issue= 11 |pages= 3715-7 |year= 1988 |pmid= 2846691 |doi=  }}
*{{cite journal   |vauthors=Diamond DC, Sleckman BP, Gregory T, etal |title=Inhibition of CD4+ T cell function by the HIV envelope protein, gp120. |journal=J. Immunol. |volume=141 |issue= 11 |pages= 3715–7 |year= 1988 |pmid= 2846691 |doi=  }}
*{{cite journal | author=Freeman SM, Saunders TL, Madden M, ''et al.'' |title=Comparison of DR beta 1 alleles from diabetic and normal individuals. |journal=Hum. Immunol. |volume=19 |issue= 1 |pages= 1-6 |year= 1987 |pmid= 2884201 |doi=  }}
*{{cite journal   |vauthors=Freeman SM, Saunders TL, Madden M, etal |title=Comparison of DR beta 1 alleles from diabetic and normal individuals. |journal=Hum. Immunol. |volume=19 |issue= 1 |pages= 1–6 |year= 1987 |pmid= 2884201 |doi=10.1016/0198-8859(87)90033-4 }}
*{{cite journal  | author=Lee BS, Rust NA, McMichael AJ, McDevitt HO |title=HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=84 |issue= 13 |pages= 4591-5 |year= 1987 |pmid= 2885840 |doi=  }}
*{{cite journal  |vauthors=Lee BS, Rust NA, McMichael AJ, McDevitt HO |title=HLA-DR2 subtypes form an additional supertypic family of DR beta alleles. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=84 |issue= 13 |pages= 4591–5 |year= 1987 |pmid= 2885840 |doi=10.1073/pnas.84.13.4591  | pmc=305136 }}
*{{cite journal  | author=Owerbach D, Rich C, Taneja K |title=Characterization of three HLA-DR beta genes isolated from an HLA-DR 3/4 insulin-dependent diabetic patient. |journal=Immunogenetics |volume=24 |issue= 1 |pages= 41-6 |year= 1986 |pmid= 3015788 |doi=  }}
*{{cite journal  |vauthors=Owerbach D, Rich C, Taneja K |title=Characterization of three HLA-DR beta genes isolated from an HLA-DR 3/4 insulin-dependent diabetic patient. |journal=Immunogenetics |volume=24 |issue= 1 |pages= 41–6 |year= 1986 |pmid= 3015788 |doi=10.1007/BF00372296 }}
*{{cite journal  | author=Wu S, Saunders TL, Bach FH |title=Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci. |journal=Nature |volume=324 |issue= 6098 |pages= 676-9 |year= 1987 |pmid= 3099214 |doi= 10.1038/324676a0 }}
*{{cite journal  |vauthors=Wu S, Saunders TL, Bach FH |title=Polymorphism of human Ia antigens generated by reciprocal intergenic exchange between two DR beta loci. |journal=Nature |volume=324 |issue= 6098 |pages= 676–9 |year= 1987 |pmid= 3099214 |doi= 10.1038/324676a0 }}
*{{cite journal  | author=Liu CP, Bach FH, Wu SK |title=Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes. |journal=J. Immunol. |volume=140 |issue= 10 |pages= 3631-9 |year= 1988 |pmid= 3129499 |doi=  }}
*{{cite journal  |vauthors=Liu CP, Bach FH, Wu SK |title=Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes. |journal=J. Immunol. |volume=140 |issue= 10 |pages= 3631–9 |year= 1988 |pmid= 3129499 |doi=  }}
*{{cite journal  | author=Steimle V, Hinkkanen A, Schlesier M, Epplen JT |title=A novel HLA-DR beta I sequence from the DRw11 haplotype. |journal=Immunogenetics |volume=28 |issue= 3 |pages= 208-10 |year= 1988 |pmid= 3137159 |doi=  }}
*{{cite journal  |vauthors=Steimle V, Hinkkanen A, Schlesier M, Epplen JT |title=A novel HLA-DR beta I sequence from the DRw11 haplotype. |journal=Immunogenetics |volume=28 |issue= 3 |pages= 208–10 |year= 1988 |pmid= 3137159 |doi=10.1007/BF00375861 }}
}}
}}
{{refend}}
{{refend}}
{{PDB Gallery|geneid=3127}}
{{Surface antigens}}
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}


{{protein-stub}}
{{protein-stub}}
{{WikiDoc Sources}}

Latest revision as of 01:37, 27 October 2017

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

HLA class II histocompatibility antigen, DRB5 beta chain is a protein that in humans is encoded by the HLA-DRB5 gene.[1]

Function

The protein encoded by this gene belongs to the HLA class II beta chain paralogues. The class II molecule is a heterodimer consisting of an alpha (DRA) and a beta chain (DRB), both anchored in the membrane. It plays a central role in the immune system by presenting peptides derived from extracellular proteins. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages).[1]

Gene structure and polymorphisms

The beta chain is approximately 26-28 kDa. It is encoded by 6 exons, exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and exon 5 encodes the cytoplasmic tail. Within the DR molecule the beta chain contains all the polymorphisms specifying the peptide binding specificities. Hundreds of DRB1 alleles have been described and typing for these polymorphisms is routinely done for bone marrow and kidney transplantation.[1]

Gene expression

DRB1 is expressed at a level five times higher than its paralogues DRB3, DRB4 and DRB5. DRB1 is present in all individuals. Allelic variants of DRB1 are linked with either none or one of the genes DRB3, DRB4 and DRB5. The presence of DRB5 is linked with allelic variants of DRB1, otherwise it is omitted. There are 4 related pseudogenes: DRB2, DRB6, DRB7, DRB8 and DRB9.[1]

See also

References

  1. 1.0 1.1 1.2 1.3 "Entrez Gene: HLA-DRB5 major histocompatibility complex, class II, DR beta 5".

Further reading